The DOI matches its Crossref record.
Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells
Abstract
RNA interference (RNAi) has been shown to be a valuable tool to specifically target gene expression in a number of organisms becoming an indispensable weapon in the arsenal in functional genomics. In this study, we demonstrate that streptolysin-O (SLO) reversible permeabilisation is an efficient method to deliver small interfering RNAs (siRNAs) to hard-to-transfect human myeloma cell lines. We used published, pre-validated siRNAs for ERK2 and non-silencing siRNA control. We transfected siRNAs into human myeloma cell lines using SLO reversible permeabilisation method. Flow cytometry and western blot analysis were performed to assess the effect of SLO on transfection efficiency and ERK2 knockdown. These experiments demonstrate that SLO reversible permeabilisation method is an efficient and easy-to-use method to deliver siRNAs into human myeloma cell lines. Optimised SLO permeabilisation method showed to transfect >80% of JIM-3, H929, RPMI8226 and U266 cells, with minimal effect on cell viability (<10%) and cell cycle. Equally important, SLO permeabilisation induced a substantial knockdown of ERK2 at the protein level. These studies demonstrate that reversible SLO permeabilisation can successfully be applied to hard-to-transfect human myeloma cell lines to effectively silence genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other groups have used SLO for delivery of siRNA (Brito et al., 2008) and imaging agents for live-cell microscopy (Teng et al., 2017).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Brito et al., 2008
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 16
- Clark, 1999, Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia, Bone Marrow Transplant., 23, 1303, 10.1038/sj.bmt.1701801 · doi:10.1038/sj.bmt.1701801
- Croonquist, 2005, The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype, Oncogene, 24, 6269, 10.1038/sj.onc.1208771 · DOI · Paper page
- Duncan, 1975, Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction, J. Cell. Biol., 67, 160, 10.1083/jcb.67.1.160 · DOI
- Fire, 1999, RNA-triggered gene silencing, Trends Genet., 15, 358, 10.1016/S0168-9525(99)01818-1 · DOI · Paper page
- Giles, 1995, Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells, Nucleic Acids Res., 23, 954, 10.1093/nar/23.6.954 · DOI
- Giles, 1998, Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells, Nucleic Acids Res., 26, 1567, 10.1093/nar/26.7.1567 · DOI
- Gomez-Benito, 2007, Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin, Cell. Signal., 19, 844, 10.1016/j.cellsig.2006.10.009 · doi:10.1016/j.cellsig.2006.10.009
- Guo, 2006, The effect of cyclin D2 shRNA on the proliferation and apoptosis of LP-1 cell, Zhonghua Xue Ye Xue Za Zhi, 27, 666
- Haughton, 2006, Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro, Gastroenterology, 131, 194, 10.1053/j.gastro.2006.04.012 · DOI
- Hurt, 2004, Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma, Cancer Cell., 5, 191, 10.1016/S1535-6108(04)00019-4 · DOI · Paper page
- Moulding, 2000, Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells, Blood, 96, 1756, 10.1182/blood.V96.5.1756 · doi:10.1182/blood.v96.5.1756
- Palmer, 1998, Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization, Embo J., 17, 1598, 10.1093/emboj/17.6.1598 · DOI
- Sandy, 2005, Mammalian RNAi: a practical guide, Biotechniques, 39, 215, 10.2144/05392RV01 · DOI
- Spiller, 1998, Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation, Blood, 91, 4738, 10.1182/blood.V91.12.4738 · DOI
- Tuschl, 2002, Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy, Mol. Interv., 2, 158, 10.1124/mi.2.3.158 · DOI · Paper page
- Zhu, 2005, Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma, Mol. Cancer Ther., 4, 787, 10.1158/1535-7163.MCT-04-0330 · DOI
Cited by
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 747
Metadata
- Authors
- Brito, J. L. R., Davies, F. E., Gonzalez, D., & Morgan, G. J.
- Venue
- Journal of Immunological Methods
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 333
- Issue
- 1-2
- Pages
- 147-155
- ISSN
- 0022-1759
- Cited by
- 22
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells. https://app.cochat.ai/papers/10.1016/j.jim.2008.01.009
- The paper
- Brito, J. L. R., Davies, F. E., Gonzalez, D., & Morgan, G. J. (2008). Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells. Journal of Immunological Methods. https://doi.org/10.1016/j.jim.2008.01.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.